David Taïeb

11.0k total citations · 2 hit papers
252 papers, 6.3k citations indexed

About

David Taïeb is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, David Taïeb has authored 252 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Surgery, 120 papers in Endocrinology, Diabetes and Metabolism and 87 papers in Cancer Research. Recurrent topics in David Taïeb's work include Adrenal and Paraganglionic Tumors (109 papers), Cancer, Hypoxia, and Metabolism (86 papers) and Pituitary Gland Disorders and Treatments (56 papers). David Taïeb is often cited by papers focused on Adrenal and Paraganglionic Tumors (109 papers), Cancer, Hypoxia, and Metabolism (86 papers) and Pituitary Gland Disorders and Treatments (56 papers). David Taïeb collaborates with scholars based in France, United States and Italy. David Taïeb's co-authors include Karel Pacák, F. Sébag, Karel Pacák, O. Mundler, Elif Hindié, Frédéric Castinetti, Joakim Crona, Anne Barlier, Electron Kebebew and Domenico Rubello and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David Taïeb

237 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension

2020 211 citations Jacques W.M. Lenders, Michiel N. Kerstens et al. Journal of Hypertension profile →
Personalized Management of Pheochromocytoma and Paraganglioma

2021 200 citations Svenja Nölting, Nicole Bechmann et al. Endocrine Reviews profile →

Peers

Countries citing papers authored by David Taïeb

Since Specialization

Citations

This map shows the geographic impact of David Taïeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Taïeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Taïeb more than expected).

Fields of papers citing papers by David Taïeb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Taïeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Taïeb. The network helps show where David Taïeb may publish in the future.

Co-authorship network of co-authors of David Taïeb

This figure shows the co-authorship network connecting the top 25 collaborators of David Taïeb. A scholar is included among the top collaborators of David Taïeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Taïeb. David Taïeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives 2024 ·Endocrine Reviews ·(unknown), Katerina Hadrava Vanova, David Taïeb, Bruna Calsina, Mercedes Robledo, Roderick Clifton‐Bligh, Karel Pacák	11
2	Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs 2024 ·Communications Biology ·Virginie Baylot, Thi Khanh Le, David Taïeb, Palma Rocchi, Laurence Colleaux	14
3	EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose–response and threshold absorbed doses 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jean‐Pierre Pouget, Pablo Mínguez Gabiña, Ken Herrmann, Désirèe Deandreis, Mark Konijnenberg, David Taïeb, Fijs W. B. van Leeuwen, Jens Kurth, Uta Eberlein, Michael Laßmann, Katharina Lueckerath, (unknown)	4
4	Recommandations conjointes du réseau National ENDOCAN-COMETE, de l’Association francophone de chirurgie endocrinienne et de la Société française d’urologie pour la prise en charge du carcinome corticosurrénalien 2023 ·Bulletin du Cancer ·Rossella Libé, Magalie Haissaguerre, Karine Renaudin, Matthieu Faron, Myriam Decaussin‐Petrucci, Frédèric Deschamps, Anne‐Paule Gimenez‐Roqueplo, Éric Mirallié, T. Murez, François Pattou, L. Rocher, David Taïeb, (unknown), Antoine Tabarin, Jérôme Bertherat, Eric Baudin, Christelle de la Fouchardière	1
5	The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors 2023 ·Journal of Nuclear Medicine ·Elif Hindié, Éric Baudin, Rodney J. Hicks, David Taïeb	3
6	Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms 2023 ·Frontiers in Oncology ·(unknown), Barry L. Shulkin, Abhishek Jha, Karel Pacák, David Taïeb	1
7	Somatostatin Receptor Theranostics for Refractory Meningiomas 2022 ·Current Oncology ·(unknown), Thomas Graillon, (unknown), Olivier Chinot, Laëtitia Padovani, David Taïeb, Éric Guedj	19
8	Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma 2022 ·European Journal of Cancer ·Christina Pamporaki, Tamara Prodanov, Leah Meuter, Annika M.A. Berends, Nicole Bechmann, Georgiana Constantinescu, Felix Beuschlein, Hanna Remde, Andrzej Januszewicz, Michiel N. Kerstens, Henri Timmers, David Taïeb, Mercedes Robledo, Jacques W.M. Lenders, Karel Pacák, Graeme Eisenhofer	29
9	Personalized Management of Pheochromocytoma and Paraganglioma breakdown → 2021 ·Endocrine Reviews ·Svenja Nölting, Nicole Bechmann, David Taïeb, Felix Beuschlein, Martin Faßnacht, Matthias Kroiß, Graeme Eisenhofer, Ashley Grossman, Karel Pacák	200
10	Therapeutic Targeting of SDHB -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid 2020 ·Clinical Cancer Research ·Yang Liu, Ying Pang, (unknown), (unknown), Veronika Caisová, (unknown), David Taïeb, Katerina Hadrava Vanova, Hans K. Ghayee, Jiřı́ Neužil, Mark Levine, Chunzhang Yang, Karel Pacák	35
11	Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension breakdown → 2020 ·Journal of Hypertension ·Jacques W.M. Lenders, Michiel N. Kerstens, Laurence Amar, Aleksander Prejbisz, Mercedes Robledo, David Taïeb, Karel Pacák, Joakim Crona, Tomáš Zelinka, Massimo Mannelli, Timo Deutschbein, Henri Timmers, Frédéric Castinetti, Henning Dralle, (unknown), Anne‐Paule Gimenez‐Roqueplo, Graeme Eisenhofer	211
12	Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB -Mutated Cluster I Pheochromocytoma and Paraganglioma 2018 ·Clinical Cancer Research ·Ying Pang, Yanxin Lu, Veronika Caisová, Yang Liu, Petra Bullova, Thanh‐Truc Huynh, Yiqiang Zhou, Di Yu, Zdeněk Fryšák, Igor Hartmann, David Taïeb, Karel Pacák, Chunzhang Yang	61
13	A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurement 2018 ·EJNMMI Research ·(unknown), (unknown), Laëtitia Padovani, S. Thureau, (unknown), (unknown), Justine Lequesne, (unknown), Pierre Véra, David Taïeb, Isabelle Gardin, Dominique Barbolosi, Sébastien Hapdey	1
14	Hypoxia-associated factor expression in low-grade and anaplastic gliomas: a marker of poor outcome 2016 ·Oncotarget ·Aurélie Tchoghandjian, Mei Yee Koh, David Taïeb, (unknown), Garth Powis, Emilie Bialecki, N Graziani, Dominique Figarella‐Branger, Philippe Métellus	4
15	Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism? 2016 ·Endocrine Related Cancer ·Carole Guérin, David Taïeb, Giorgio Treglia, Thierry Brue, André Lacroix, F. Sébag, Frédéric Castinetti	47
16	Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB -Associated Metastatic Pheochromocytoma and Paraganglioma 2015 ·Clinical Cancer Research ·Ingo Janssen, Elise M. Blanchet, Karen T. Adams, Clara C. Chen, Corina Millo, Peter Herscovitch, David Taïeb, Electron Kebebew, Hendrik Lehnert, Antonio Tito Fojo, Karel Pacák	180
17	Sentinel lymph node biopsy in head and neck melanoma: A single institution analysis. 2014 ·PubMed ·(unknown), Serge Cammilleri, Roch Giorgi, Jean‐Jacques Grob, David Taïeb, (unknown), P. Dessi, Nicolas Fakhry	2
18	Myelolipomatous Adrenal Adenoma and Adrenal Scintigraphy: A Case Presentation and Review of Literature 2014 ·Journal of Endocrinology and Metabolism ·(unknown), Prasanna Santhanam, David Taïeb	1
19	Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement 2012 ·Journal of Nuclear Medicine ·Pierre‐Yves Salaün, L. Campion, Claire Bournaud, Alain Faivre-Chauvet, Jean‐Philippe Vuillez, David Taïeb, C. Ansquer, Caroline Rousseau, Françoise Borson‐Chazot, Stéphane Bardet, A. Oudoux, Bertrand Cariou, Éric Mirallié, Chien‐Hsing Chang, Robert M. Sharkey, David M. Goldenberg, Jean‐François Chatal, Jacques Barbet, Françoise Kraeber‐Bodéré	44
20	ArgBP2-Dependent Signaling Regulates Pancreatic Cell Migration, Adhesion, and Tumorigenicity 2008 ·Cancer Research ·David Taïeb, Julie Roignot, (unknown), (unknown), (unknown), Anne Pierrès, (unknown), Philippe Soubeyran	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact